News

Oxford scientists lead the way in cutting-edge cancer research

Oxford scientists will play a key role in ground-breaking research into new radiotherapy and immunotherapy treatments for cancer patients following a multi-million pound investment.

Researchers from the city’s Cancer Research UK Centre will be collaborating with scientists across the UK, following the announcement today of the charity’s Centres’ Network Accelerator Awards.

Designed to inspire new approaches to beating cancer, the awards will invest around £16 million UK-wide over the next five years.

Oxford researcher secures funding for powerful imaging technique in pancreatic cancer

Pancreatic Cancer Research Fund (PCRF) is funding six new research projects with a total of £1 million - bringing the charity’s support for research into the UK’s most lethal cancer to over £8 million. This is the third year that PCRF has invested £1 million in a single funding round. In total, the charity has funded 40 cutting edge research projects across the UK and Ireland, worth over £6 million.

Early signs of success for pioneering treatment at Oxford Early Phase Clinical Trials Unit

An Oxford cancer patient who was told she may have only eighteen months to live is free from signs of the disease after taking a trial drug for almost three years. Susan Cakebread received her pioneering treatment at the Early Phase Clinical Trials Unit at Oxford’s Churchill Hospital which aims to discover new treatments for the future.

Pancreatic Cancer UK funds new Oxford researcher in the fight against pancreatic cancer

National charity Pancreatic Cancer UK has today announced the award of £100,000 to a research team based at the University of Oxford. The grant will allow the addition of a new member to the team as part of the charity’s pioneering Future Leaders Fund, amounting to over £500,000 in similar grants across the UK. This award will support a student through a DPhil project which will be supervised by Dr Emmanouil Fokas and Professor Eric O’Neill.

Scientists discover how to better map brain tumours

Scientists have discovered a protein that helps map the edge of brain tumours more clearly so they show up on magnetic resonance imaging (MRI) scans, according to new research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool.

The laboratory research, carried out in rats, could lead to clinical trials aimed at improving the accuracy of brain tumour treatment.

WEE-ding out cancer

It is well known that mutations drive cancer cell growth and resistance to treatment.  However, these mutations can also become a weak point, or Achilles’ heel, for a tumour. Now, scientists at the University of Oxford have found a new way to kill cancer cells with mutations in a key cancer gene called SETD2.

Pages

About Us
We aim to enhance clinical and basic cancer research in Oxford with the ultimate goal of increasing cancer cure rates.
Research
In Oxford, we have a great wealth of broad-ranging expertise and a powerful network of cancer researchers.
Study With Us
Our graduate training programmes for both scientists and clinicians are internationally recognised.
Subscribe to RSS - News